Phathom Pharmaceuticals's total assets for Q3 2025 were $240.29M, a decrease of -3.97% from the previous quarter. PHAT total liabilities were $662.82M for the fiscal quarter, a 1.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.